Maryam Sheikhi
Overview
Explore the profile of Maryam Sheikhi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
308
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Homayounfar S, Ayatollahi H, Ferns G, Hemmatan Attarbashi R, Gharib M, Sheikhi M, et al.
Caspian J Intern Med
. 2024 Dec;
16(1):66-72.
PMID: 39619760
Background: Comprehensive molecular assessment of cancers could open up new horizons for novel therapies. Fibroblast growth factor receptor 1 (FGFR1) gene amplification has been previously demonstrated in non-small cell lung...
2.
Sheikhi M, Siyadat P, Rostami M, Sadeghian M, Zahiri E, Ghorbani M, et al.
Caspian J Intern Med
. 2024 Oct;
15(4):579-588.
PMID: 39359452
Background: NUP98 gene fusions in acute myeloid leukemia (AML) have recently attracted much interest. Despite substantial research illuminating the roles of NUP98 fusions in the course of AML, their impacts...
3.
Sheikhi M, Rostami M, Ferns G, Ayatollahi H, Siyadat P, Ayatollahi Y, et al.
Caspian J Intern Med
. 2024 May;
15(2):202-214.
PMID: 38807730
Background: Although genetic mutations in additional sex-combs-like 1 (ASXL1) are prevalent in acute myeloid leukemia (AML), their exact impact on the AML prognosis remains uncertain. Hence, the present article was...
4.
Khoshnegah Z, Siyadat P, Rostami M, Sheikhi M, Ghorbani M, Mansouritorghabeh H
J Thromb Thrombolysis
. 2024 May;
57(6):1018-1030.
PMID: 38722521
COVID-19 has been associated with alterations in coagulation. Recent reports have shown that protein C and S activities are altered in COVID-19. This may affect the complications and outcome of...
5.
Ayatollahi H, Boroumand-Noughabi S, Ferns G, Sheikhi M, Siyadat P, Rostami M, et al.
Caspian J Intern Med
. 2023 Nov;
14(4):694-702.
PMID: 38024167
Background: Autophagy is a pathway for the degradation of cytoplasmic components, which plays an essential role in various cellular and physiological processes, including cell renewal and survival, and immune responses....
6.
Jafarian A, Jafaripour M, Gharib M, Salehi M, Roshan N, Etemad S, et al.
Iran J Pathol
. 2023 Aug;
18(2):134-139.
PMID: 37600581
Background & Objective: Epithelial ovarian cancer (EOC) is the most prevalent type of ovarian cancer. Previous studies have elucidated different pathways for the progression of this malignancy. The mutation in...
7.
Naghinezhad J, Alenabi A, Ayatollahi H, Sheikhi M, Sadeghian M, Khoshnegah Z, et al.
Med J Islam Repub Iran
. 2023 Aug;
37:68.
PMID: 37575689
Background: Acute myeloid leukemia (AML) is the most common acute leukemia in adults and accompanies a worse survival. In this study, gene expression levels of 5 key players of apoptosis,...
8.
Yazdandoust E, Sadeghian M, Shams S, Ayatollahi H, Saadatpour Y, Siyadat P, et al.
Iran J Pathol
. 2022 Dec;
17(4):419-426.
PMID: 36532642
Background & Objective: Acute myeloid leukemia (AML) is a hematopoietic malignancy caused by genetic abnormalities. Currently, molecular and genetic factors are routinely used as diagnostic and prognostic markers. FLT-3 is...
9.
Boroumand-Noughabi S, Khoshnegah Z, Jamehdar S, Ayatollahi H, Sheikhi M, Rostami M, et al.
Med J Islam Repub Iran
. 2022 Nov;
36:99.
PMID: 36419945
The autophagy machinery is reported to be employed by Coronaviruses during their replication. Beclin-1 (BECN1) and protein 1 light chain 3 (LC3) are two key elements in the autophagy process,...
10.
The Emerging Roles of Aldehyde Dehydrogenase in Acute Myeloid Leukemia and Its Therapeutic Potential
Rahmati A, Goudarzi S, Sheikhi M, Siyadat P, Ferns G, Ayatollahi H
Anticancer Agents Med Chem
. 2022 Jun;
23(3):246-255.
PMID: 35692153
Acute myeloid leukemia (AML) is a malignant disorder characterized by myeloid differentiation arrest and uncontrolled clonal expansion of abnormal myeloid progenitor cells. AML is the most common malignant bone marrow...